Antibiotic susceptibility pattern of group B streptococcal isolates from maternal genital tract
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20193035Keywords:
Aantibiotics, Genital tract, Group B streptococci, Resistance, SusceptibilityAbstract
Background: Group B streptococcus (GBS) is one of the important cause of early onset neonatal sepsis in developed countries leading to increased neonatal morbidity and mortality. Penicillin and Ampicillin are the drugs of choice for prevention of GBS infections. Antibiotic resistance amongst GBS isolates is an emerging health problem affecting neonates. Hence, this study was performed to determine the antibiotic susceptibility pattern of Group B Streptococcus (GBS) in a population of pregnant women.
Methods: A prospective study was done to screen pregnant women for vaginal and rectal GBS colonization during their regular visits to antenatal clinic. Todd-Hewitt broth, an enrichment medium for GBS was used for isolation. The antibiotic susceptibility pattern of the isolates were studied.
Results: A total of 300 pregnant women were screened for GBS colonization. GBS colonization rate in our study was 2.3%. The antibiotic susceptibility pattern of the isolates revealed that none of the isolates were resistant to penicillin or clindamycin, while resistance was noted to erythromycin (14.3%) and tetracycline (71.4%).
Conclusions: GBS continues to remain sensitive to Penicillin which is the drug of choice for prevention and treatment of GBS. Consistent surveillance of antibiotic sensitivity pattern of GBS as well as for other organisms implicated in new born sepsis and maternal infections is required to formulate guidelines for prevention and treatment.
References
American Academy of Pediatrics and Committee on Fetus and Newborn Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics. 1997;99:489-96.
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR. 2002;51:1-22.
Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR. 1996;45(RR-7):1-24.
Hsueh PR, Teng LJ, Lee LN, Ho SW, Yang PC, Luh KT. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 2001;45(11):3205-8.
Prakash K, ravindran PC, Sharma KB. Group B Hemolytic streptococci and their serological types in human infections. Indian J Med Res 1976;64:1001-7.
Kishore K, Deorari AK, Paul VK, Singh M, Bhujwala RA. Group B streptococcal colonization and neonatal outcome in North India. Indian J Med Res. 1986;84:492-4.
Regan JA, Mark A, Klebanoff MA and Nugent RP. The Epidemiology of GBS Colonization in Pregnancy. Obstet Gyneco. 1991;77:604-10.
Kulkarni AA, Pawar SG, Dharmadhikarai CA, Kulkarni RD. Colonization of pregnant women and their newborn infants with Group B streptococci. Indian J Med Microbiol. 2001;19:1-4.
Nwachukwu NC, Utsalo SJ, Kanu I, Anyanwu EC. Genital colonization of Group B Streptococcus at term pregnancy in Calabar, Nigeria. 2007. Internet J Pediat Neonatol. 2007;7:9.
Orrett FA. Colonization with Group B Streptococci in pregnancy and outcome in infected neonates in Trinidad. Pediatr Int. 2003;45:319-23.
Eren A, Kucukercan M, Oguzoglu N, Unal N, Karateke A. The carriage of Group B Streptococci in Turkish pregnant women and its transmission rate in newborns and serotype distribution. Turk J Pediatr. 2005;47:28-33.
Joachim A, Matee M, Masswawe FA, Layamuya EF. Maternal and neonatal colonization of group B streptococcus at Muhimbili National Hospital in Dares Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009;9:437-45.
Tor-Udom S, Tor-Udom P, Hiriote W. The Prevalence of Streptococcus agalactiae (Group B) Colonization in Pregnant Women at Thammasat Hospital. J Med Assoc Thai. 2006;89(4):411-4.
Manning SD, Neighbors K, Tallman PA, Gillespie B, Marrs CF, Borchardt SM, et al. Prevalence of Group B Streptococcus Colonization and Potential for Transmission by Casual Contact in Healthy Young Men and Women. Clin Infect Dis. 2004;39:381-7.
Lopardo HA, Vidal P, Jeric P, Centron D, Paganini H, Facklam RR. The Argentinian Streptococcus Study Group. Elliott J. Six-Month multicenter study on invasive infections due to Group B streptococci in Argentina. J. Clin. Microbiol. 2003;41(10):4688-94.
Melin P, Rodríguez-Cuns G, Fernández WV, De Mol P. Antimicrobial susceptibility of Streptococcus agalactiae isolated from patients in Belgium, 1989-1991 and 1996-1999. In: Martin R., Tagg J.R., editors. Streptococci and streptococcal diseases: entering the new millennium. Proceedings of the XIV Lancefield International Symposium on Streptococci and Streptococcal Diseases. New Zealand: Securacopy, Auckland. 2000;305-309.
Traub WH, Leonhard B. Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy. 1997;43:10-20.
Heelan JS, Hasenbein ME, McAdam AJ. Resistance of Group B Streptococcus to selected antibiotics, including erythromycin and clindamycin. J. Clin. Microbiol. 2004; 42(3):1263-4.
